Redefining the value in partnerships ahead of DCAT Week

As the industry emerges from a prolonged funding slowdown, the roundtable highlights cautious optimism. Rather than a broad-based recovery, participants describe a selective, research-driven uptick focused on clinic-ready assets and higher-complexity modalities. Discussions have shifted from speculative experimentation to practical considerations, including manufacturability, timeline efficiency and the ability to scale reliably. This suggests growth that is deliberate, technology selective and weighted toward assets with clearer commercial pathways.

LATEST VIDEO

Latest news

22nd April 2026

Lilly to Acquire Kelonia Therapeutics in $7 Billion Deal

22nd April 2026

FDA Approves Merck’s Oral Daily HIV Medicine

21st April 2026

Alcami to Acquire Contract Packaging Organization Tjoapack

21st April 2026

INDENA EXHIBITS SOLUTIONS FOR COMPLEX MOLECULE MANUFACTURING AND NEXT-GENERATION CDMO SERVICES AT CPHI JAPAN 2026

21st April 2026

CPHI Americas 2026 to focus on regulatory shifts, AI and biotech innovation

16th April 2026

CPHI Americas 2026 to focus on regulatory shifts, AI and biotech innovation

16th April 2026

INDENA DRIVES NUTRACEUTICAL ADVANCEMENTS: FOCUS ON EYE HEALTH & HEALTHY AGING AT TOKYO HEALTHFOOD EXPO 2026

8th April 2026

Ofichem unifies brands under single CDMO and pharmaceutical supplier

7th April 2026

Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

2nd April 2026

Resyca Announces the Appointment of Deborah Jones as New CEO

1st April 2026

Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion

This week’s featured articles

A woman’s view from the HAS Group

Breaking Barriers: Women Scientists Rising to Leadership in Pharma

Strategic Growth in Biologics Manufacturing: Insights from Lonza's Acquisition of the Vacaville Site

Grifols’ supply chain strategy offers lessons beyond saline

Axplora: Mastering complexity

Partnered with top industry events and organisations